IM Cannabis Corp. reported a 10% decrease in annual revenue for 2023, attributing it to negative currency fluctuations and the Israel-Hamas war's impact on operations. Despite a 68% drop in Q4 gross profit, the company sees growth opportunities in Germany following new cannabis legislation. Financial highlights include a 7.5% increase in gross profit year-over-year, a 49% decrease in general and administrative expenses, and a 43% reduction in operating expenses. IM Cannabis' shares rose 7.33% following the announcement.